Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$27.57
$35.33
$23.01
$47.40
$230.65M0.4678,443 shs71,815 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$3.09
-6.1%
$4.06
$3.00
$16.16
$61.84M1.9125,647 shs76,792 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$71.94
-0.6%
$64.07
$23.47
$77.00
$231.95M0.0675,954 shs96,359 shs
Profound Medical stock logo
PROF
Profound Medical
$5.74
-2.5%
$6.83
$4.80
$8.95
$215.18M0.72116,311 shs82,165 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
0.00%+5.43%-31.57%-31.16%+15.45%
Outset Medical, Inc. stock logo
OM
Outset Medical
-6.08%-0.96%-26.25%-32.68%-79.19%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.65%+0.13%+7.60%+10.15%+112.15%
Profound Medical stock logo
PROF
Profound Medical
-2.55%-1.54%-15.59%-9.89%+13.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$27.57
$35.33
$23.01
$47.40
$230.65M0.4678,443 shs71,815 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$3.09
-6.1%
$4.06
$3.00
$16.16
$61.84M1.9125,647 shs76,792 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$71.94
-0.6%
$64.07
$23.47
$77.00
$231.95M0.0675,954 shs96,359 shs
Profound Medical stock logo
PROF
Profound Medical
$5.74
-2.5%
$6.83
$4.80
$8.95
$215.18M0.72116,311 shs82,165 shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
0.00%+5.43%-31.57%-31.16%+15.45%
Outset Medical, Inc. stock logo
OM
Outset Medical
-6.08%-0.96%-26.25%-32.68%-79.19%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
-0.65%+0.13%+7.60%+10.15%+112.15%
Profound Medical stock logo
PROF
Profound Medical
-2.55%-1.54%-15.59%-9.89%+13.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Electromed, Inc. stock logo
ELMD
Electromed
2.75
Moderate Buy$43.7558.69% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40
Hold$10.00223.62% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
3.00
Buy$74.002.86% Upside
Profound Medical stock logo
PROF
Profound Medical
2.67
Moderate Buy$11.50100.35% Upside

Current Analyst Ratings Breakdown

Latest OM, PDEX, ELMD, and PROF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/21/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-)Hold (C+)
9/15/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHoldStrong-Buy
9/11/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Boost Price TargetBuy$70.00 ➝ $74.00
9/4/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+)Buy (B-)
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Set Price Target$50.00
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Boost Price TargetBuy$36.00 ➝ $47.00
8/24/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
DowngradeBuy (B-)Hold (C+)
8/21/2026
Outset Medical, Inc. stock logo
OM
Outset Medical
DowngradeSell (D-)Sell (E+)
8/12/2026
Profound Medical stock logo
PROF
Profound Medical
DowngradeSell (D-)Sell (E+)
8/7/2026
Outset Medical, Inc. stock logo
OM
Outset Medical
UpgradeSell (E+)Sell (D-)
8/6/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
UpgradeHold (C+)Buy (B-)
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Electromed, Inc. stock logo
ELMD
Electromed
$73.78M3.13$0.67 per share41.36$5.10 per share5.41
Outset Medical, Inc. stock logo
OM
Outset Medical
$117.80M0.49N/AN/A$6.99 per share0.44
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$77.55M2.97$3.88 per share18.55$14.92 per share4.82
Profound Medical stock logo
PROF
Profound Medical
$19.09M10.99N/AN/A$1.83 per share3.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$1.3136.76N/AN/A11.34%15.71%13.37%N/A
Outset Medical, Inc. stock logo
OM
Outset Medical
-$81.65M-$4.09N/AN/AN/A-63.06%-61.67%-28.25%11/9/2026 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$13.66M$4.1317.4221.41N/A17.62%25.13%16.02%10/29/2026 (Estimated)
Profound Medical stock logo
PROF
Profound Medical
-$42.57M-$0.98N/AN/AN/A-171.57%-63.03%-51.24%11/12/2026 (Estimated)

Latest OM, PDEX, ELMD, and PROF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/3/2026Q4 2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.87+$0.20$0.87$19.20 million$20.41 million
8/6/2026Q2 2026
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.7167-$0.80-$0.0833-$0.97$28.97 million$31.64 million
8/6/2026Q2 2026
Profound Medical stock logo
PROF
Profound Medical
-$0.22-$0.26-$0.04$0.26$4.75 million$2.48 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
Outset Medical, Inc. stock logo
OM
Outset Medical
1.03
5.19
4.11
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.28
4.10
2.45
Profound Medical stock logo
PROF
Profound Medical
N/A
6.46
5.31

Institutional Ownership

CompanyInstitutional Ownership
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Profound Medical stock logo
PROF
Profound Medical
47.86%

Insider Ownership

CompanyInsider Ownership
Electromed, Inc. stock logo
ELMD
Electromed
10.50%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.50%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
45.90%
Profound Medical stock logo
PROF
Profound Medical
1.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Electromed, Inc. stock logo
ELMD
Electromed
1978.37 million7.36 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
31018.80 million18.33 millionNot Optionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2063.20 million1.73 millionNot Optionable
Profound Medical stock logo
PROF
Profound Medical
16236.53 million35.98 millionOptionable

Recent News About These Companies

Why Profound Medical Corp.’s (PROF) Stock Is Up 5.03%
Profound Medical Appoints Richard Fabian President
Profound Medical names interim CFO
Profound Medical Announces Management Change
Profound Medical Announces Management Change
Profound Medical Announces Management Change
Profound Medical (PROF) Q2 2026 Earnings Call Transcript
Profound Medical Q2 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Electromed stock logo

Electromed NYSE:ELMD

$27.57 0.00 (0.00%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$27.64 +0.07 (+0.24%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$3.09 -0.20 (-6.08%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$3.07 -0.02 (-0.65%)
As of 07:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$71.94 -0.47 (-0.65%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$72.01 +0.07 (+0.10%)
As of 04:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$5.74 -0.15 (-2.55%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$5.74 0.00 (-0.09%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.